• Our Science
    Our Approach
    • Defined Bacterial Consortia
    • Product Engine
    • Manufacturing
    • Intellectual Property
    Scientific Insights
    • Publications
  • Pipeline & Programs
    • Pipeline
    • VE202
    • VE303
    • VE707
  • Commitment to Patients
    Our Focus
    • How It Works
    Disease Areas
    • Inflammatory Bowel Disease
    • C. difficile Infection
    Clinical Trials
    • Trials
    • COLLECTiVE202
    • RESTORATiVE303
    • Expanded Access Policy
  • Who We Are
    Company
    • Mission
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    Careers
    • Working at Vedanta
    • Open Positions
  • News
    • Press Releases
  • Our Science
    • Defined Bacterial Consortia
    • Product Engine
    • Manufacturing
    • Intellectual Property
    • Publications
  • Pipeline & Programs
    • Pipeline
    • VE202
    • VE303
    • VE707
  • Commitment to Patients
    • How It Works
    • Inflammatory Bowel Disease
    • C. difficile Infection
    • Trials
    • COLLECTiVE202
    • RESTORATiVE303
    • Expanded Access Policy
  • Who We Are
    • Mission
    • Leadership
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Working at Vedanta
    • Open Positions
  • News
    • Press Releases
« Previous
Next »

Vedanta Biosciences
19 Blackstone Street
Cambridge, MA 02139
USA
Phone: 857-706-1427
Email: [email protected]

  • Company
    • Mission
    • Team
    • Working at Vedanta
  • Explore
    • Publications
    • Pipeline
    • Clinical Trials
    • Press Releases
  • Policy
    • Terms and Conditions
    • Privacy Policy
    • Expanded Access Policy

© 2025 Vedanta Biosciences, Inc. All Rights Reserved.

  • Visit us on X
  • Visit us on Linkedin